1. Epigenetics
  2. Histone Acetyltransferase
  3. CBP/p300-IN-19 hydrochloride

CBP/p300-IN-19 hydrochloride is a potent and selective p300/CBP HAT inhibitor with IC50s of 1.4, 2.2, >100, >100 µM for p300-HAT, CBP-HAT, PCAF, Myst3, respectively. CBP/p300-IN-19 hydrochloride shows antitumor activity.

For research use only. We do not sell to patients.

CBP/p300-IN-19 hydrochloride Chemical Structure

CBP/p300-IN-19 hydrochloride Chemical Structure

CAS No. : 2592638-14-5

Size Price Stock Quantity
5 mg USD 240 Get quote 4 - 6 weeks 4 - 6 weeks 3 - 5 weeks
10 mg USD 390 Get quote 4 - 6 weeks 4 - 6 weeks 3 - 5 weeks
25 mg USD 820 Get quote 4 - 6 weeks 4 - 6 weeks 3 - 5 weeks
50 mg USD 1310 Get quote 4 - 6 weeks 4 - 6 weeks 3 - 5 weeks
100 mg USD 2100 Get quote 4 - 6 weeks 4 - 6 weeks 3 - 5 weeks
200 mg   Get quote  
500 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of CBP/p300-IN-19 hydrochloride:

Top Publications Citing Use of Products

View All Histone Acetyltransferase Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

CBP/p300-IN-19 hydrochloride is a potent and selective p300/CBP HAT inhibitor with IC50s of 1.4, 2.2, >100, >100 µM for p300-HAT, CBP-HAT, PCAF, Myst3, respectively. CBP/p300-IN-19 hydrochloride shows antitumor activity[1].

IC50 & Target[1]

Myst3

>100 μM (IC50)

p300-HAT

1.4 μM (IC50)

CBP-HAT

2.2 μM (IC50)

PCAF

>100 μM (IC50)

In Vitro

CBP/p300-IN-19 hydrochloride (compound 29) shows antiproliferative activity with EC50s of 5.3, 8.5, 6.2, 4.4, 1.2, 4.3, 3.6, 8.7, 6.4 µM for MCF-7, MDA-MB231, LNCaP, PC-3, PANC-1, MDA-PANC-28, Molm-13, MV4;11, RPMI-8226 cells, respectively[1].
CBP/p300-IN-19 hydrochloride (0, 5, 10 µM; 12 h) dose-dependenly inhibits the acetylation of H3K18, H3K9 and K27[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: Kasumi-1 leukemia cells
Concentration: 0, 5, 10 µM
Incubation Time: 12 h
Result: Dose-dependently inhibited the acetylation of H3K18, H3K9 and K27.
Molecular Weight

514.01

Formula

C30H28ClN3O3

CAS No.
SMILES

[H]Cl.C1(C2=CC=C(C3=COC=C3)C=C2)=NC=C(OCC4CCNCC4)N=C1C5=CC=C(C6=COC=C6)C=C5

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
CBP/p300-IN-19 hydrochloride
Cat. No.:
HY-146277A
Quantity:
MCE Japan Authorized Agent: